Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene + BST in Advanced Primary Liver Cancer
NCT03167775Unknown
- Start
- Nov 2016
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Elemene. Primary endpoints: Disease Control Rate at 6 months and 6-Months Survival Rate. Status: unknown.
02
Drugs
Elemene
Beyond the preview
Go deeper on NCT03167775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167775.